EUIPO trademark

RETAHVERA

Opposition periodEUIPOWord markClass 5

"RETAHVERA" is a word mark owned by Eli Lilly and Company, filed at the EUIPO on September 16, 2026. It is in its opposition period and covers class 5 (Pharmaceuticals).

View Eli Lilly and Company portfolioGet this data via the API
Official EUIPO record
RETAHVERA
Word mark as filed with the EUIPO
Status
Opposition period
Filed
September 16, 2026
Registered
Not yet
Expires
Not recorded
Application no.
019423157
Registration no.
Not yet
Office
EUIPO
European Union Intellectual Property Office
Mark type
Word mark
1 class
Ownership

Who owns RETAHVERA

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Eli Lilly and Company

LLY

8,043 trademarks in the portfolioView company

Representative

Page White Farrer (Germany) LLP

Page White Farrer (Germany) LLP

Goods and services

What the mark covers

The products and services RETAHVERA is filed for, grouped by Nice class.

  • Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of alcohol use disorder, alopecia, Alzheimer’s disease, asthma, atopic dermatitis, autoimmune diseases and disorders, blood diseases and disorders, cancer, cardiovascular disease, central nervous system diseases and disorders, Crohn’s disease, dementia, dermatological diseases and disorders, diabetes, dyslipidemia, endocrine diseases and disorders, gastrointestinal diseases and disorders, hearing loss, heart failure, infectious diseases, inflammation and inflammatory diseases and disorders, inflammatory bowel disease, kidney diseases and disorders, liver diseases and disorders, mental disorders, metabolic diseases and disorders, migraines, multiple sclerosis, neurodegenerative diseases and disorders, neurological disorders, obesity, obstructive sleep apnea, opioid use disorder, osteoarthritis, pain, Parkinson’s disease, psoriasis, psoriatic arthritis, pulmonary diseases, retinal disease, rheumatoid arthritis, tobacco use disorder, ulcerative colitis, vascular diseases and vision loss; pharmaceutical preparations for weight management; vaccines for human use

FAQ

About RETAHVERA

Who owns the trademark "RETAHVERA"?

The EUIPO trademark "RETAHVERA" (application 019423157) is owned by Eli Lilly and Company.

What is the status of "RETAHVERA"?

Its status at the EUIPO is: opposition period.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull RETAHVERA and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_01a0ae2f-2cd6-76c9-b4dc-c7b011c6de52
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_01a0ae2f-2cd6-76c9-b4dc-c7b011c6de52",
  "object": "trademark",
  "mark_text": "RETAHVERA",
  "status": {
    "primary": "pending",
    "stage": "pending_opposition"
  },
  "office_code": "EM",
  "application_number": "019423157",
  "filing_date": "2026-09-16",
  "nice_classes": [
    5
  ],
  "owners": [
    {
      "name": "Eli Lilly and Company",
      "entity_id": "ent_019eb749-c2e4-7669-8d85-00996fda299e"
    }
  ]
}